|
 
Last update: |
 |
|
|
08-Jul-2009
|
 |
|
|
Arch Hellen Med, 26(3), May-June 2009, 345-354 REVIEW Percutaneous radiofrequency ablation of lung malignancy: Technique and results E. SOTIROPOULOU, F. LASPAS, A. MANATAKI, P. TSAGkOULI, E. SEFEROS, N. PTOHIS, L. THANOS |
Lung cancer is the commonest malignancy. Although surgical resection is the treatment of choice, most patients, due to advanced disease, are not surgical candidates. In addition, other cancers often metastasize into the lung parenchyma. Chemotherapy and external-beam radiation have not greatly affected the outcome in patients with unresectable disease. Radiofrequency ablation (RFA) is a recognised minimally invasive technique, used for the treatment of primary and metastatic malignant lesions in various solid organs. In order to evaluate the efficacy and safety of RFA in the treatment of cancerous lung lesions, the international literature was searched and the most recent data from studies which included non-surgical candidates with primary lung cancer or patients with pulmonary metastases were reviewed.
Key words: CT, Lung cancer, Metastasis, Radiofrequency ablation.
